These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7872842)

  • 21. Neuroleptic discontinuation and tardive dyskinesia risk.
    Sherr JD; Medoff D; Thaker G
    Am J Psychiatry; 1999 Jul; 156(7):1125-6. PubMed ID: 10401483
    [No Abstract]   [Full Text] [Related]  

  • 22. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL; Wagner RL
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tardive dyskinesia in young mentally retarded individuals.
    Gualtieri CT; Schroeder SR; Hicks RE; Quade D
    Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.
    Viguera AC; Baldessarini RJ; Hegarty JD; van Kammen DP; Tohen M
    Arch Gen Psychiatry; 1997 Jan; 54(1):49-55. PubMed ID: 9006400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive dyskinesia--reversible and persistent.
    Jeste DV; Potkin SG; Sinha S; Feder S; Wyatt RJ
    Arch Gen Psychiatry; 1979 May; 36(5):585-90. PubMed ID: 35116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.
    Kleinman I; Schachter D; Jeffries J; Goldhamer P
    Hosp Community Psychiatry; 1993 Dec; 44(12):1189-91. PubMed ID: 7907571
    [No Abstract]   [Full Text] [Related]  

  • 27. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
    Llorca PM; Vaiva G; Lancon C
    Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497
    [No Abstract]   [Full Text] [Related]  

  • 28. Tardive dyskinesia.
    Murray JB
    Genet Psychol Monogr; 1980 Nov; 102(2):161-90. PubMed ID: 6110612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible withdrawal dyskinesia associated with quetiapine.
    Michaelides C; Thakore-James M; Durso R
    Mov Disord; 2005 Jun; 20(6):769-70. PubMed ID: 15747370
    [No Abstract]   [Full Text] [Related]  

  • 30. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroleptic-induced dyskinesias in children.
    Campbell M; Grega DM; Green WH; Bennett WG
    Clin Neuropharmacol; 1983; 6(3):207-22. PubMed ID: 6138148
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic-free intervals in the treatment of schizophrenia.
    Pyke J; Seeman MV
    Am J Psychiatry; 1981 Dec; 138(12):1620-1. PubMed ID: 6118068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The concept of supersensitivity psychosis.
    Kirkpatrick B; Alphs L; Buchanan RW
    J Nerv Ment Dis; 1992 Apr; 180(4):265-70. PubMed ID: 1348269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supersensitivity psychosis.
    Peet M
    J Clin Psychiatry; 1991 Feb; 52(2):90. PubMed ID: 1671568
    [No Abstract]   [Full Text] [Related]  

  • 36. [Late extrapyramidal hyperkinesis and neuroleptic withdrawal dyskinesia. Practical problems].
    Hoffmann C; Faust V
    Fortschr Med; 1983 Mar; 101(11):470-6. PubMed ID: 6133824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
    Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
    J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic-induced supersensitivity psychosis.
    Chouinard G; Jones BD; Annable L
    Am J Psychiatry; 1978 Nov; 135(11):1409-10. PubMed ID: 30291
    [No Abstract]   [Full Text] [Related]  

  • 40. Medication-free minors with schizophrenia.
    Cohen D
    Am J Psychiatry; 2001 Feb; 158(2):324. PubMed ID: 11156827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.